Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors A Pazos, JM Palacios Brain research 346 (2), 205-230, 1985 | 1730 | 1985 |
Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors A Pazos, R Cortes, JM Palacios Brain research 346 (2), 231-249, 1985 | 1117 | 1985 |
The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site A Pazos, D Hoyer, JM Palacios European journal of pharmacology 106 (3), 539-546, 1984 | 798 | 1984 |
Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors A Pazos, A Probst, JM Palacios Neuroscience 21 (1), 123-139, 1987 | 533 | 1987 |
Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors A Pazos, A Probst, JM Palacios Neuroscience 21 (1), 97-122, 1987 | 511 | 1987 |
Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites D Hoyer, A Pazos, A Probst, JM Palacios Brain research 376 (1), 85-96, 1986 | 488 | 1986 |
The distribution of adenosine A1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals J Fastbom, A Pazos, JM Palacios Neuroscience 22 (3), 813-826, 1987 | 368 | 1987 |
Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites D Hoyer, A Pazos, A Probst, JM Palacios Brain research 376 (1), 97-107, 1986 | 364 | 1986 |
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors R Linge, L Jiménez-Sánchez, L Campa, F Pilar-Cuéllar, R Vidal, A Pazos, ... Neuropharmacology 103, 16-26, 2016 | 307 | 2016 |
Autoradiography of antidepressant binding sites in the human brain: localization using [3H] imipramine and [3H] paroxetine R Cortes, E Soriano, A Pazos, A Probst, JM Palacios Neuroscience 27 (2), 473-496, 1988 | 257 | 1988 |
A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity S Mato, V Chevaleyre, D Robbe, A Pazos, PE Castillo, OJ Manzoni Nature neuroscience 7 (6), 585-586, 2004 | 256 | 2004 |
Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain S Mato, E Del Olmo, A Pazos European Journal of Neuroscience 17 (9), 1747-1754, 2003 | 250 | 2003 |
Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors MR Pazos, N Mohammed, H Lafuente, M Santos, E Martínez-Pinilla, ... Neuropharmacology 71, 282-291, 2013 | 243 | 2013 |
BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice E Aso, A Ozaita, EM Valdizán, C Ledent, Á Pazos, R Maldonado, ... Journal of neurochemistry 105 (2), 565-572, 2008 | 223 | 2008 |
Pharmacological characteristics and anatomical distribution of [3H] oxytocin-binding sites in the Wistar rat brain studied by autoradiography MJ Freund-Mercier, ME Stoeckel, JM Palacios, A Pazos, JM Reichhart, ... Neuroscience 20 (2), 599-614, 1987 | 222 | 1987 |
Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 … A Pazos, D Hoyer, JM Palacios European journal of pharmacology 106 (3), 531-538, 1984 | 217 | 1984 |
Dopamine receptors in human brain: autoradiographic distribution of D1 sites R Cortes, B Gueye, A Pazos, A Probst, JM Palacios Neuroscience 28 (2), 263-273, 1989 | 198 | 1989 |
Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome C Martínez-Cué, P Martínez, N Rueda, R Vidal, S García, V Vidal, ... Journal of Neuroscience 33 (9), 3953-3966, 2013 | 191 | 2013 |
Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants? A Lahmame, C Del Arco, A Pazos, M Yritia, A Armario European journal of pharmacology 337 (2-3), 115-123, 1997 | 185 | 1997 |
Strategies for producing faster acting antidepressants A Adell, E Castro, P Celada, A Bortolozzi, A Pazos, F Artigas Drug discovery today 10 (8), 578-585, 2005 | 179 | 2005 |